GlassScriptPhysician profile
Tejal Patel
NPI 1538672217
$832.97
in general payments reported to CMS, 2019-2025
19 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.42 · 2022: $303 · 2023: $69.75 · 2024: $233 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $179.75 | 2023-2025 | Tecvayli, Darzalex, Talvey |
| Abbvie INC. | $102.12 | 2022-2025 | |
| Incyte Corporation | $65.84 | 2022-2024 | Jakafi, Monjuvi |
| Beone Medicines USA, INC. | $53.10 | 2025 | Tevimbra, Brukinsa |
| Astrazeneca Pharmaceuticals LP | $52.02 | 2022 | |
| Puma Biotechnology, INC. | $49.64 | 2022-2024 | |
| Beigene USA, INC. | $43.13 | 2022-2024 | Brukinsa |
| Bayer Healthcare Pharmaceuticals INC. | $40.13 | 2022 | |
| Pfizer INC. | $37.50 | 2022-2024 | |
| Lilly USA, LLC | $36.23 | 2022-2024 | Jaypirca, Verzenio |
| Genzyme Corporation | $28.64 | 2021-2025 | |
| Ipsen Biopharmaceuticals, INC | $23.82 | 2022 | |
| Emd Serono, INC. | $23.46 | 2024 | |
| Pharmacyclics LLC, An Abbvie Company | $20.98 | 2023 | Imbruvica |
| Seagen INC. | $19.34 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $18.27 | 2021 | |
| Karyopharm Therapeutics INC. | $14.02 | 2022 | |
| Gilead Sciences, INC. | $13.03 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.